BioSpace News Archive

Deals

Suitors Weigh Bids for Sanofi’s $3B European Generics Biz

The portfolio consists of acute, chronic and oncology products.

January 11, 2018
·
1 min read
Business

Medtronic to Restructure, Unknown Number of Employees Impacted

Changes are coming to Medtronic.

January 11, 2018
·
2 min read
·
Alex Keown
Business

Vice Admiral Matthew L. Nathan, M.D., Former Surgeon General of the U.S. Navy, Joins Humanetics Medical Advisory Board

In this capacity, Dr. Nathan will work with the Company to help guide its efforts to develop FDA-approved drugs for the protection of warfighters.

January 11, 2018
·
2 min read
Can-Fite 12 Months’ Activities & Milestones for 2018

Can-Fite announced its near-term milestones for 2018, including events related to the rheumatoid arthritis/psoriasis drug Piclidenoson and the liver disease drug Namodenoson.

January 11, 2018
·
7 min read
Business

BioLegend and New York Genome Center Enter into Exclusive Global License and Research Agreement for CITE-seq, a Novel Technique for Multidimensional Single Cell Analysis

BioLegend (“BioLegend”) and the New York Genome Center (“NYGC”) announced today that they have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq technology for use in the research field.

January 11, 2018
·
4 min read
Business

Forty Seven to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer

Forty Seven today announced an agreement with Merck KGaA, Darmstadt, Germany to conduct a Phase 1b clinical trial combining Hu5F9-G4 with avelumab* in patients with ovarian cancer.

January 11, 2018
·
5 min read
Deals

LENSAR Acquires Laser Business Assets of Precision Eye Services

Financial terms of the acquisition were not disclosed.

January 11, 2018
·
3 min read
Biotech Beach

Biosense Webster Release: First Patient Enrolled in U.S. IDE Study to Evaluate the Potential of New Device to Reduce Stroke Risk in Atrial Fibrillation Patients

The study will evaluate the safety and effectiveness of the WaveCrest LAAO System in closure of the LAA and evaluate reduction of embolic stroke in AFib patients who cannot tolerate chronic OAC.

January 11, 2018
·
3 min read
Policy

Endo Comments on United States Attorney’s Office Grand Jury Subpoena Relating to Products Containing Oxymorphone

The subpoena broadly requests documents including, among others, those produced in past or pending lawsuits and those relating to product safety and efficacy, overdoses, diversion, thefts, overprescribing, abuse/misuse, dependency or tolerance, withdrawal, addictiveness, adverse events and manipulation.

January 11, 2018
·
3 min read
BioMidwest

Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility

Baxter today announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device.

January 11, 2018
·
4 min read